Moreover, though the anti-depressive effect of ketamine has been suggested to be mediated by activation of mTOR based on pre-clinical studies (194), a recent randomized control trial found that mTOR inhibition increased the effect of antidepressants in patients with major depression (195). This evidence concerns the gene MTOR and major depressive disorder.